Details About Generic Salt ::  Amobarbi

Main Medicine Class:: Sedative and hypnotic,barbiturate   

(am-oh-BAR-bih-tahl SO-dee-uhm)
Amytal Sodium
Class: Sedative and hypnotic/barbiturate

 

Drugs Class ::

 Action Depresses sensory cortex; decreases motor activity; alters cerebellar function and produces drowsiness, sedation and hypnosis.

Indications for Drugs ::

 Indications Relief of anxiety; short-term therapy for insomnia; induction of preanesthetic sedation.

Drug Dose ::

 Route/Dosage

INSOMNIA

ADULTS: PO/IM/IV 65 to 200 mg at bedtime.

SEDATION

ADULTS: PO/IM/IV 30 to 50 mg bid or tid. CHILDREN: PO/IM 2 to 6 mg/kg/dose.

Contraindication ::

 Contraindications Hypersensitivity to barbiturates; history of addiction to sedative-hypnotic drugs; history of porphyria; severe liver impairment; respiratory disease with dyspnea; patients with nephritis.

Drug Precautions ::

 Precautions

Pregnancy: Category D. Lactation: Excreted in breast milk. Children: Safety and efficacy not established in children < 6 yr. Elderly: Reduce dosage. Drug dependence: Tolerance or psychologic and physical dependence may occur with continued use. Renal or hepatic impairment: Use with caution; reduce dosage.

PATIENT CARE CONSIDERATIONS


Drug Side Effects ::

 Adverse Reactions

CV: Bradycardia; hypotension; syncope. CNS: Drowsiness; agitation; confusion; headache; hyperkinesia; ataxia; CNS depression; paradoxical excitement; nightmares; psychiatric disturbances; hallucinations; insomnia; dizziness. GI: Nausea; vomiting; constipation. HEMA: Blood dyscrasias (agranulocytosis, thrombocytopenia). HEPA: Liver damage. RESP: Hypoventilation; apnea; laryngospasm; bronchospasm. OTHER: Hypersensitivity reactions (eg, angioedema, rashes, exfoliative dermatitis); fever; injection site reactions (eg, local pain, thrombophlebitis).

Drug Mode of Action ::  

 Action Depresses sensory cortex; decreases motor activity; alters cerebellar function and produces drowsiness, sedation and hypnosis.

Drug Interactions ::

 Interactions

Alcohol, CNS depressants: Depressant effects of these drugs may be enhanced. Anticoagulants, beta-blockers, calcium-channel blockers (eg, Verapamil) theophyllines: Activity of these drugs may be reduced. Anticonvulsants: Serum concentrations of carbamazepine, valproic acid and succinimides may be reduced. Valproic acid may increase barbiturate serum levels. Corticosteroids: Effectiveness may be reduced. Estrogens, estrogen-containing oral contraceptives: Effectiveness may be reduced.

Drug Assesment ::

 Assessment/Interventions

  • Obtain patient history, including drug history and any known allergies.
  • Ensure that serum bilirubin level has been determined before beginning long-term therapy, especially in patients with hepatic disease.
  • Monitor vital signs before and during IV infusion.
  • Assess sleep patterns and mental status before beginning therapy and monitor periodically during therapy.
  • Observe IV site during and after infusion. Extravasation or inadvertent intra-arterial injection may cause tissue necrosis, arterial spasm, thrombosis, or gangrene.
  • Monitor children and elderly patients for adverse reactions, including marked excitement, confusion, restlessness, or depression.
  • If hypersensitivity reaction develops, withhold dose and notify physician.
  • When administering by IV infusion, keep resuscitation equipment at bedside.
  • If signs of extravasation or phlebitis appear at injection site, discontinue IV infusion and notify physician.
  • Implement safety measures to prevent falls, especially with elderly patients.
  • Restrict amount of drug available to patient during early therapy.
OVERDOSAGE: SIGNS & SYMPTOMS
  Respiratory depression, CNS depression progressing to Cheyne-Stokes respiration, oliguria, tachycardia, hypotension, hypothermia, coma, shock, cessation of electrical activity in brain (extreme overdose)

Drug Storage/Management ::

 Administration/Storage

  • May be given in oral, IM (deep), or IV form. Do not administer SC.
  • Reconstitute solution with Sterile Water for Injection, rotating vial to mix. Do not shake vial. Solution should clear within 5 min.
  • Do not dilute with Lactated Ringer’s solution.
  • Do not administer if solution is discolored or if precipitate is present.
  • After reconstitution, inject solution within 30 min.
  • Do not exceed IV infusion rate of 1 ml/min or 100 mg/min. Over-rapid administration may result in respiratory depression, apnea, and hypertension.
  • To avoid tissue irritation, do no inject > 5 ml IM into any one site.
  • Store at room temperature. Do not freeze.

Drug Notes ::

 Patient/Family Education

  • Advise patient not to increase dosage or stop therapy without advice of physician.
  • Instruct patient to avoid alcohol, nicotine, and caffeine products.
  • Advise patient that drug may cause drowsiness, and to use caution while driving or performing other tasks requiring mental alertness.
  • Inform patient to report the following symptoms to physician: Excessive sleepiness, fatigue, nausea, vomiting.

Disclaimer ::

The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.

DOWNLOAD OUR ANDROID APP

One of the 1st in India.High Quality Generic Medicine Portal Android Application for Online Oreder & Information.

For More Join Our Membership and Get Additional 25% off on Meds, also get MLM Benefits to get a permanent earning source.

Join Membership How to Search Medicine
Android App

We would like to keep you updated with special notifications.